CAD and peripheral arterial disease: We have identified a novel population of CD34+/M-cad+ hematopoietic progenitor cells in adult mouse bone marrow that improved blood flow recovery better than CD34+/M-cad− and CD34−/M-cad+ cells in an atherosclerotic mouse model of PAD.